Brain Lesions
8
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
83.3%
-3.2% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage
Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation
Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases
DYNA EMBOLIZATION - Pilot Study of IV Dyna CT and CBV Imaging Techniques
FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions
Orientation Agnosia: Clinical and Anatomical Study
Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain
To Investigate the Event Related Potentials (ERPs) of Patients With Brain Lesions